TGA cautions against over-buying medicines
The TGA’s response to reports of local-level out-of-stocks in some pharmacies due to over-buying
Published
Related content
-
TGA response to coronavirus (COVID-19)
Information updated following the cessation of the Therapeutic Goods (Medical Devices—Accredited Pathology Laboratories) (COVID-19 Emergency) Exemption 2020 -
TGA to permit conditional substitution to ease serious shortages
In response to the COVID-19 pandemic, the TGA is implementing Serious Shortage Medicine Substitution Notices -
Critical medicines supply modelling supports return to elective surgery
New modelling demonstrates that supply of critical medicines for ventilating patients supports a return to elective surgery